Bright Minds Biosciences (DRUG) SEC Filings & 10K Form

$1.05
+0.01 (+0.97%)
(As of 05/2/2024 ET)

Recent Bright Minds Biosciences SEC Filings

DateFilerForm TypeView
02/26/2024
7:18 PM
Bright Minds Biosciences (Subject)
McDonald Ian (Filed by)
Form SC 13D/A
02/26/2024
7:10 PM
Bright Minds Biosciences (Subject)
McDonald Ian (Filed by)
Form SC 13D/A
02/12/2024
8:56 PM
Bright Minds Biosciences (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/18/2024
11:57 AM
Bright Minds Biosciences (Subject)
McDonald Ian (Filed by)
Form SC 13D
12/29/2023
3:30 PM
Bright Minds Biosciences (Filer)
Form 20-F
Registration statement / Annual report / Transition report  
12/22/2023
5:26 PM
Bright Minds Biosciences (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/08/2023
5:00 AM
Bright Minds Biosciences (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/20/2023
12:49 PM
Bright Minds Biosciences (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/12/2023
3:55 PM
Bright Minds Biosciences (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/22/2023
2:36 PM
Bright Minds Biosciences (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NASDAQ:DRUG) was last updated on 5/2/2024 by MarketBeat.com Staff

From Our Partners